rs182650126

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001365536.1(SCN9A):​c.2248A>G​(p.Ile750Val) variant causes a missense change. The variant allele was found at a frequency of 0.00346 in 1,589,074 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0027 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0035 ( 10 hom. )

Consequence

SCN9A
NM_001365536.1 missense

Scores

1
12
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:15

Conservation

PhyloP100: 4.15

Publications

37 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012462795).
BP6
Variant 2-166280452-T-C is Benign according to our data. Variant chr2-166280452-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 157597.
BS2
High Homozygotes in GnomAdExome4 at 10 AD,SD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN9ANM_001365536.1 linkc.2248A>G p.Ile750Val missense_variant Exon 14 of 27 ENST00000642356.2 NP_001352465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN9AENST00000642356.2 linkc.2248A>G p.Ile750Val missense_variant Exon 14 of 27 NM_001365536.1 ENSP00000495601.1 Q15858-1
SCN9AENST00000303354.11 linkc.2248A>G p.Ile750Val missense_variant Exon 14 of 27 5 ENSP00000304748.7 Q15858-1
SCN9AENST00000409672.5 linkc.2215A>G p.Ile739Val missense_variant Exon 14 of 27 5 ENSP00000386306.1 Q15858-3
SCN9AENST00000645907.1 linkc.2215A>G p.Ile739Val missense_variant Exon 14 of 27 ENSP00000495983.1 Q15858-4
SCN9AENST00000454569.6 linkc.2215A>G p.Ile739Val missense_variant Exon 14 of 15 1 ENSP00000413212.2 A0A0C4DG82

Frequencies

GnomAD3 genomes
AF:
0.00268
AC:
408
AN:
152086
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00465
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00442
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00378
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.00245
AC:
515
AN:
210268
AF XY:
0.00234
show subpopulations
Gnomad AFR exome
AF:
0.000696
Gnomad AMR exome
AF:
0.00252
Gnomad ASJ exome
AF:
0.000323
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00375
Gnomad NFE exome
AF:
0.00350
Gnomad OTH exome
AF:
0.00318
GnomAD4 exome
AF:
0.00354
AC:
5089
AN:
1436870
Hom.:
10
Cov.:
30
AF XY:
0.00346
AC XY:
2463
AN XY:
712154
show subpopulations
African (AFR)
AF:
0.000331
AC:
11
AN:
33186
American (AMR)
AF:
0.00262
AC:
108
AN:
41218
Ashkenazi Jewish (ASJ)
AF:
0.000156
AC:
4
AN:
25628
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39086
South Asian (SAS)
AF:
0.000847
AC:
70
AN:
82682
European-Finnish (FIN)
AF:
0.00400
AC:
208
AN:
52058
Middle Eastern (MID)
AF:
0.000873
AC:
5
AN:
5726
European-Non Finnish (NFE)
AF:
0.00413
AC:
4529
AN:
1097798
Other (OTH)
AF:
0.00259
AC:
154
AN:
59488
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
234
468
703
937
1171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00267
AC:
407
AN:
152204
Hom.:
1
Cov.:
32
AF XY:
0.00261
AC XY:
194
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.000650
AC:
27
AN:
41508
American (AMR)
AF:
0.00458
AC:
70
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
1
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.00442
AC:
47
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00378
AC:
257
AN:
68010
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
21
43
64
86
107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00262
Hom.:
6
Bravo
AF:
0.00237
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000820
AC:
3
ESP6500EA
AF:
0.00404
AC:
33
ExAC
AF:
0.00199
AC:
240
Asia WGS
AF:
0.000578
AC:
2
AN:
3476

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:15
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
May 12, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19763161, 24820863, 24737233, 32707200, 22539570, 27301361, 28073787, 28235406, 23891399, 29176367, 27608006, 27916648, 28488083, 30478917, 31664448, 22826602, 21698661) -

Mar 28, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SCN9A: BS2 -

Jun 09, 2020
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:4
Apr 05, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 19, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 20, 2017
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Small fiber neuropathy Pathogenic:1
Sep 01, 2014
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Primary erythromelalgia Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Inherited Erythromelalgia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Sep 03, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Channelopathy-associated congenital insensitivity to pain, autosomal recessive Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Aug 22, 2023
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SCN9A-related disorder Benign:1
Oct 27, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Paroxysmal extreme pain disorder Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Uncertain
0.030
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.59
.;D;.;.;D;.;.
Eigen
Uncertain
0.59
Eigen_PC
Uncertain
0.62
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.90
D;.;D;D;D;D;D
M_CAP
Benign
0.083
D
MetaRNN
Benign
0.012
T;T;T;T;T;T;T
MetaSVM
Pathogenic
0.96
D
MutationAssessor
Uncertain
2.7
.;M;.;.;M;M;.
PhyloP100
4.2
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-0.89
N;.;.;.;.;N;.
REVEL
Uncertain
0.62
Sift
Uncertain
0.022
D;.;.;.;.;D;.
Sift4G
Uncertain
0.039
D;D;.;.;.;D;.
Vest4
0.49
MVP
0.71
MPC
0.11
ClinPred
0.032
T
GERP RS
5.9
Varity_R
0.27
gMVP
0.29
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs182650126; hg19: chr2-167136962; COSMIC: COSV105146574; COSMIC: COSV105146574; API